Navigation Links
Research Leads to First Treatment for Drug-Resistant HIV

'm so grateful it has turned into a drug and been approved by the FDA so quickly."

The molecule Ghosh created is expected to be available to physicians this year, he said.

"I think that this drug will have a sizeable impact on the current therapy for AIDS and HIV infection," said Hiroaki Mitsuya (pronounced HE-row-ah-key MIT-sue-ya), chief and principal investigator of the Experimental Retrovirology Section at the National Cancer Institute who collaborated with Ghosh in this research.

Molecules are made up of groups of atoms bonded together. These bonded groups form an oddly shaped structure with sections that branch off and others that form loops. Different sections are responsible for various behaviors of the molecule.

Ghosh's designed compound has selected features of naturally occurring molecules that improve its ability to fight HIV. The result is a variation of one of the most common treatments existing today, a protease inhibitor.

Protease is an enzyme necessary for HIV to reproduce properly. A protease inhibitor binds to protease, making it unusable by the virus. Without the use of protease, HIV is incapable of infecting cells and harming the patient. By reducing the amount of active virus, patients' bodies have an increased ability to fend off opportunistic infections, the leading cause of death for those with AIDS.

Eight protease inhibitors are currently on the market and have greatly improved the quality of life for those suffering from HIV, Ghosh said. These inhibitors, however, lose their effectiveness over time, often cause severe side effects and are ineffective against drug-resistant HIV strains, he said.

Treatment using the molecule designed by Ghosh has fewer associated side effects because the dose required is significantly less than those for existing protease inhibitors. The molecule also is smaller than those that make up current protease inhibitors and is much
'"/>




Page: 1 2 3 4

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children

Post Your Comments:
(Date:11/9/2009)...swire/ -- HUYA Bioscience International, a leade...ion, today announced a strategic partnership with ...ity of China. The agreement is another in a series...China,s leading research and development instituti...t and commercialization of novel biopharmaceutical...
(Date:11/9/2009)...y involving 2,453 women ages 18 to 68 found that l...a partner contributed to higher ratings of pleasur...have long been recommended to women to improve the...isk of vaginal tearing, yet strikingly little avai...ts or associated vaginal symptoms. , The study,...
(Date:11/8/2009)...Newswire-USNewswire/ -- The American Public Health...llness provisions in the health reform bill passed...his bill, the House takes important steps toward u...reforms and moving our health system from one that...on keeping people healthy," said Georges C. Benjam...
(Date:11/8/2009)... out of the game later, doctors say , , ...re the talk of the NFL this season, sidelining suc...k Willie Parker. , Officials at the American Po...f Podiatric Sports Medicine are warning athletes t...ts like football and lacrosse. , "Many fall spo...
(Date:11/8/2009)...book called "Preventing and Healing AIDS Thro...o shows that AIDS is a result of multiple, repeate...mmune system stressor agents, which can be either ...motional. , Oakland, CA ... 2009, cell biologists, physicians, chemists and o...
Breaking Medicine News(10 mins):Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
...0 Jobs, HARRISBURG, Pa., Dec. 28 /PRNewswire-USNe...e Williamsport Hospital and Medical Center campus,... a $12.5 million grant,from the commonwealth, the ...ears -- for debt service to the Lycoming County In...
...,Acquisition Corp. ("Echo" or the "Company") (OTC ...unced at its special meeting of stockholders today... provide stockholders,additional time to consider ...us previously mailed to Echo stockholders.,The Ech...
...ission,to provide service, support and hope to all... America (LFA) submitted comments today to Commiss...stration (SSA), regarding a,proposed change to the...be submitted 5 days,before an administrative heari...
...helped for at least a decade , , FRIDAY, D...ly and safely corrects severe myopia for at least ...pia, which is caused by excessive curving of the e...from some degree of nearsightedness. , Laser surge...
...Year,s as the,"world championship" of weight loss,...nd promises. For millions of well-intentioned diet... and, ultimately,disappointment., (See video fro...mber,by Harris Interactive(R) on behalf of GlaxoSm...
... A review published in Dermatologic Therapy revea... procedures in the same way as women but require h...here has recently become a growing interest in cos... often require more units of Botox than women whic...
Other Medicine News:Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 2Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 3Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 4Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 5Health News:Lupus Foundation of America Urges Social Security Administration Not to Adopt Proposed 5-Day Rule 2Health News:Laser Surgery Can Correct Nearsightedness 2Health News:VIDEO from Medialink and GlaxoSmithKline: Really Think You Can 'Lose 30 Pounds in 30 Days?' 2
(Date:11/6/2009)...re-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX )...ncial results for the second quarter ended October... on Wednesday, November 18, 2009 at 5:00 PM EST. ...uss those results on Thursday, November 19, 2009 a...rter Results Conference Call Instructions ,, ...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: ...c products for regenerative healing, today reporte...ptember 30, 2009. ,, "During the third quarter ... new biologic products MagniFuse(TM) Bone Graft, ... Innovative Grafting," said Sam Owusu-Akyaw, Presi...
Breaking Medicine Technology:Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Social background weighs heavily on teenage diet 58327 1Social background weighs heavily on teenage diet 58327 2New Treatment May Beat Melanoma 58326 1New Treatment May Beat Melanoma 58326 2New Treatment May Beat Melanoma 58326 3
...rk Hurtt, Chief Medical Officer, to present interi... Trial in Acute Spinal Cord Injury, HOPKINTON, Ma...(Nasdaq: ALSE ) announced that on April 15, 2008,...ss the CETHRIN development,program as a member of ...ing a congressional briefing on Capitol Hill focus...
...EGO, April 9, 2008 Favrille, Inc.,(Nasdaq: FVRL ...specific,active immunotherapies for the treatment ... data cutoff date for the Company,s Phase 3 regist...merly FavId(R)) following,Rituxan(R) in patients w....,As of the data cutoff date, 205 of the 349 patie...
Other Medicine Technology:Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 2Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 3Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 4Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 5
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: